GSK, J&J to trial next-generation malaria vaccine
Tuesday, June 7, 2011 - 09:00
in Health & Medicine
LONDON (Reuters) - Even as the world's first malaria vaccine gets closer to the market, two leading drug firms have joined forces to test a next-generation shot against the mosquito-borne disease that kills 800,000 people a year.